“We are excited to announce the acquisition of New Aera as we feel its TAV technology can be used to improve the lives of both oxygen therapy patients, existing non-invasive ventilation patients, and ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results ...
Inogen, Inc. INGN has been gaining on the back of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a strong product portfolio ...
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...
Greetings and welcome to the Inogen Fourth Quarter and Year-end 2020 earnings conference call. [Operator Instructions] I would now like to turn the conference over to your host, Matt Pigeon, Investor ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a ...
Greetings. Welcome to the Inogen 2022 Fourth Quarter Financial Results. At this time, all participants are in a listen-only mode [Operator Instructions]. Please note, this conference is being recorded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results